# Use of Selincro and Impact on Usual Practice

> **NCT02492581** · — · COMPLETED · sponsor: **University of Bordeaux** · enrollment: 700 (actual)

## Conditions studied

- Alcohol Dependence

## Interventions

- **DRUG:** Nalmefene

## Key facts

- **NCT ID:** NCT02492581
- **Lead sponsor:** University of Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 700 (ACTUAL)
- **Last updated:** 2018-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02492581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02492581, "Use of Selincro and Impact on Usual Practice". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02492581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*